Pay in 4 interest-free payments of $7.45 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
As the field evolves, evaluating therapies across broader cardiometabolic health domainsas well as other body systemswill be critical to understanding the full benefit of GLP-1s
Cassiopea Glenmark Pharmaceuticals Sources Primary Research Interviews Pharmaceutical manufacturers and drug developers Healthcare providers and endocrinologists Regulatory affairs specialists Pharmaceutical distributors and retailers Others Magazines Pharmaceutical Executive BioPharma Dive Diabetes Care Magazine Drug Discovery & Development Others Journals Pharmaceutical Executive BioPharma Dive Diabetes Care Magazine Drug Discovery & Development Others Newspapers Financial Times The Wall Street Journal Reuters Health News Bloomberg Healthcare Others Associations American Diabetes Association (ADA) European Association for the Study of Diabetes (EASD) International Diabetes Federation (IDF) Pharmaceutical Research and Manufacturers of America (PhRMA) Others Public Domain Sources World Health Organization (WHO) publications Centers for Disease Control and Prevention (CDC) reports European Medicines Agency (EMA) publications National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Others Proprietary Elements CMI Data Analytics Tool GLP-1 Receptor Agonist Market CMI Existing Repository of Information for the Last 8 Years * Definition: Global GLP-1 receptor agonist market involves pharmaceutical products that mimic the effects of naturally occurring glucagon-like peptide-1 (GLP-1)
17 Dulaglutide EMA product information (2023)
PD and LBD Clinical studies relevant to this section are summarised in table 2
In addition to Wegovy, Walgreens Weight Management supports several other GLP-1 agonist medications for weight loss such as tirzepatide (Zepbound) and liraglutide (Saxenda)
Stir gently to combine
